InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (13 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
13
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Duncan Jason, Directeur Juridique. Officer active across 1 company, notably Albireo Pharma, INC.. Aggregated, 20 disclosures have been published. Breakdown: 0 buy · 13 sells. Total volume traded: €98k. Activity tracked since 24 June 2021. The latest transaction was disclosed on 19 January 2023 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations20 total
3,296 sharesCommon StockSEC:0001209191-23-014741:0
55,000 shares0Common StockSEC:0001209191-23-005335:0
55,000 shares0Common StockSEC:0001209191-23-004950:0
228 shares@ US$43.802.0% of flowCommon StockSEC:0001209191-23-004451:0
938 shares@ US$43.90448.2% of flowCommon StockSEC:0001209191-23-004223:0
104 shares@ US$19.57640.4% of flowCommon StockSEC:0001209191-22-054490:0
96 shares@ US$19.53760.4% of flowCommon StockSEC:0001209191-22-054490:1
456 shares@ US$19.39631.9% of flowCommon StockSEC:0001209191-22-054490:2
106 shares@ US$24.67730.5% of flowCommon StockSEC:0001209191-22-043100:0
240 shares@ US$33.071.8% of flowCommon StockSEC:0001209191-22-025522:0
416 shares@ US$24.88222.0% of flowCommon StockSEC:0001209191-22-004809
416 shares@ US$24.88222.3% of flowCommon StockSEC:0001209191-22-004809:0
10,800 shares0Common StockSEC:0001209191-22-004060:0
10,800 shares0Common StockSEC:0001209191-22-004060
95 shares@ US$28.85080.6% of flowCommon StockSEC:0001209191-21-061556:0
95 shares@ US$28.85080.5% of flowCommon StockSEC:0001209191-21-061556
90 shares@ US$34.130.6% of flowCommon StockSEC:0001209191-21-048160
90 shares@ US$34.130.6% of flowCommon StockSEC:0001209191-21-048160:0
9,137 shares@ US$24.0439.5% of flowCommon StockSEC:0001209191-21-043467
9,137 shares@ US$24.0445.6% of flowCommon StockSEC:0001209191-21-043467:0
20 of 20 declarations
About Duncan Jason
Jason Duncan is the Chief Legal Officer and General Counsel at Albireo Pharma, Inc. He is responsible for managing the company's legal affairs and regulatory compliance. With a strong background in business law, he plays a key role in protecting the company's interests while ensuring compliance with applicable laws.
